Jie-Yu Liu

[Ochre Bio @OchreBio]

🚀 Announcing our new multi-year data license agreement with @GSK to investigate the drivers of #liverdisease!

Read the announcement ➡️
https://t.co/KgY2AZVYWI

[Ochre Bio @OchreBio]

🚀 We're hiring across our New York, Oxford and Taipei sites!

If you're interested in joining a fast-paced, innovative liver biotech company, get in touch!

Apply now ➡️ https://t.co/ElGgcAaByo

[Buck Institute @BuckInstitute]

What?? Bacteria that cause leprosy, one of the world’s oldest diseases, can reprogram cells to safely increase liver size in adult mice. Discovery in @CellRepMed could lead to treatments to renew aging livers and avoid transplantation (isn’t science cool?) https://t.co/djxsJ8joFX

[Ochre Bio @OchreBio]

We are passionate about the potential of #AI & #BigData, particularly the possibilities in enhancing speed & reducing research costs in #drugdevelopment. We are co-hosting a #Symposium at our Taipei lab.
Details:https://t.co/t26A7qfnHe
Sign Up to attend:https://t.co/aPyRWVqvbS

[Jie-Yu Liu @JieYuLiu4]

@SouroullasLab @oncogenejournal @SZintheLab Woohoo congrats!!!

[Ochre Bio @OchreBio]

We are hiring for our New York Lab, know anyone who might be interested?

https://t.co/Uncw29RJk8

#biotech #Job #NewYork #hiring #HIRINGNOW

[Ochre Bio @OchreBio]

We at Ochre Bio are a perfect blend of #Biology , #Chemistry and #computation.
Click below and see what some of our teammates have to say about their experience in @OchreBio .
#hiringnow #humanresources
https://t.co/PUsJIiSdxV

[Ochre Bio @OchreBio]

Have a look at what our CSO @QuinWills has to say about 'deep phenotyping' and how it's been applied at @OchreBio for developing drugs for chronic liver diseases.
https://t.co/Kv5hJjD7qJ via @Labiotech_eu

[Ochre Bio @OchreBio]

Today our Lead Development team shipped the first batch of #oligonucleotides manufactured in our #Oxford chemistry lab to colleagues in #Taipei for use in their experiments,Congrats team!
#liverdisease #liverhealth #rna #therapeutics #biotech #rnatherapies #regenererativemedicine

[Ochre Bio @OchreBio]

Today's coffee chat is all about #RNA!

Check out the chat with some of our chemists from Ochre Bio's Lead Development team about the potential and future of #RNAtherapies.

https://t.co/NOLMQ8feLR

[Ochre Bio @OchreBio]

Ochre's CSO Quin Wills is having coffee chats with our amazing team ☕️

Check out his second Coffee Chat with Dr Ana Cuervo, the architect behind many of our human primary cell complex (co-)culture models, at our Oxford target validation lab.

https://t.co/zJOapbeloL

[Jie-Yu Liu @JieYuLiu4]

This collaboration to evaluate the effects of RNA therapy directly in human livers preclinically is a step change for liver research, that we hope will lead to treatments for a number of liver diseases, and one day reduce the burden of liver... https://t.co/6IE1iQged7

[Ochre Bio @OchreBio]

Come join @QuinWills tomorrow in person @Cambridge_Uni @join_ef for a fireside chat + networking event to learn more about Quin's journey into startups coming from an MD/PhD background.

Snacks and drinks provided 😁

📅12 May, 7:30 – 10:00pm

https://t.co/AZVtTuNaVB

[Jie-Yu Liu @JieYuLiu4]

@AlexJColville @OchreBio @Thomas_Rando Awww that’s so sweet of you ❤️

[bioRxiv @biorxivpreprint]

Death-seq identifies regulators of cell death and senolytic therapies https://t.co/tyqNzux0Nz #bioRxiv

[Jie-Yu Liu @JieYuLiu4]

@BrackLab Interested!!! Please count me in!